A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) Patients
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to investigate the effects of AZD1236 compared with placebo
("inactive substance") in COPD patients by analysing biomarkers for inflammation and tissue
degradation in blood, urine and sputum.